![](/img/cover-not-exists.png)
Regression of Sight-Threatening Macular Edema in Type 2 Diabetes Following Treatment With the Anti-Tumor Necrosis Factor Monoclonal Antibody Infliximab
Sfikakis, P. P., Markomichelakis, N., Theodossiadis, G. P., Grigoropoulos, V., Katsilambros, N., Theodossiadis, P. G.Volume:
28
Language:
english
Journal:
Diabetes Care
DOI:
10.2337/diacare.28.2.445
Date:
February, 2005
File:
PDF, 694 KB
english, 2005